Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2012
11/28/2012CN101899028B New furanditerpenoid compound, preparation method and application thereof
11/28/2012CN101897677B Imperatorin sustained release tablets and preparation method thereof
11/28/2012CN101857598B Furocoumarin compound with hypertension activity reducing function and preparation method thereof
11/28/2012CN101780122B Preparation method of a water-soluble gingko extract
11/28/2012CN101696183B (Z)-2-phenyl-3-(pyrrol-2-yl)-acrylonitrile derivative as well as salts, composition, preparation method and application thereof
11/28/2012CN101683406B Application of a traditional Chinese medicine composition in preparation of medicament for treating and preventing hypertension
11/28/2012CN101653546B Application of Chinese medicinal composition in preparation of medicament for treating rheumatic heart disease
11/28/2012CN101647792B Use of treprostinil to treat and prevent ischemic lesions
11/28/2012CN101632796B Application of Chinese medicinal composition in preparing medicament for treating acute heart failure
11/28/2012CN101618116B Method for preparing blood-nourishing angelica capsules by using powder coatings
11/28/2012CN101617827B Supramolecular composite of isosteviol or derivative thereof and preparation method thereof
11/28/2012CN101612312B Application of Chinese medicinal composition in preparation of medicament for treating diabetic complication
11/28/2012CN101590178B Application of traditional Chinese medicine composition in preparation of medicine for treating refractory premature beat of elderly patient
11/28/2012CN101321517B Solid, orally administrable pharmaceutical drug delivery system with a fast release of the active substance
11/28/2012CN101279955B N-substituted thiamorpholine derivate as DPP-IV inhibitor and medical use thereof
11/28/2012CN101139625B Ace inhibitory peptides from plant materials
11/27/2012US8318800 Tablet form for oral administration of amiodarone hydrochloride or dronedarone hydrochloride; antiarrhythmic agents
11/27/2012US8318782 Mitotic kinesin inhibitor
11/27/2012US8318744 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
11/27/2012US8318721 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/27/2012US8318696 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative
11/27/2012US8318689 SiRNA-based cancer treatment
11/27/2012US8318467 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes
11/27/2012US8318235 On site polymerization of vinylidenefluoride and hexafluoropropolyene to desired thickness, dip coating stent and/or catheter having complex configuration into latex emulsion containing medication; reducing material loss; customized variable dosaging
11/27/2012US8318169 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
11/27/2012CA2615975C Compositions for reducing the incidence of drug induced arrhythmia
11/27/2012CA2530706C 2-amino-bicyclo[3.1.0] hexane-2,6-dicarboxylic ester derivative
11/27/2012CA2526816C The use of oxicam compounds
11/27/2012CA2525214C Macrocyclic quinazoline derivatives as antiproliferative agents
11/27/2012CA2513310C Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia
11/27/2012CA2493122C Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
11/27/2012CA2467374C Indole-2-carboxamides as factor xa inhibitors
11/27/2012CA2359360C In vitro screening method for identifying selective binding partners for 5-ht5-receptors
11/22/2012WO2012157790A1 Composition containing ginseng berry extract for activating mitochondria
11/22/2012WO2012157479A1 Ctrp6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
11/22/2012WO2012156970A1 Salvia sclarea seed oil for use in the treatment of cardiovascular diseases or anxiety disorders
11/22/2012WO2012156551A1 Methods for cell regeneration after acute myocardial infarction
11/22/2012WO2012156311A1 Use of cathepsin k inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure
11/22/2012WO2012156225A1 Use of a sulfurated compound for the treatment of hyper-homocysteinemia.
11/22/2012WO2012155295A1 Industrial production method for producing antihypertensive bioactive peptide
11/22/2012WO2012135868A3 Compositions and methods for the treatment and prevention of cardiac ischemic injury
11/22/2012WO2012131656A3 Compounds for use as therapeutic agents affecting p53 expression and/or activity
11/22/2012WO2012100229A3 Compositions and methods for cardiovascular disease
11/22/2012WO2012087180A9 Method for treating acute cerebral and spinal blood flow disorders of an ischaemic or haemorrhagic nature
11/22/2012US20120296403 Methods and compounds for muscle growth
11/22/2012US20120296072 N-terminally chemically modified protein compositions and methods
11/22/2012US20120295988 Pharmaceutical Compositions of Dispersions of Amorphous Drugs Mixed with Polymers
11/22/2012US20120295985 Methods for improving blood glucose control
11/22/2012US20120295980 Compounds and methods for delivery of prostacyclin analogs
11/22/2012US20120295976 Composition and/or method for preventing recurrence of stroke
11/22/2012US20120295969 Novel Muscle Relaxant Using Negatively Charged Gold with Choline
11/22/2012US20120295968 Pharmaceutical Composition Comprising Cannabinoids
11/22/2012US20120295957 Prevention of tissue ischemia and related compositions
11/22/2012US20120295956 Prevention of tissue ischemia and related methods
11/22/2012US20120295952 Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
11/22/2012US20120295947 Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
11/22/2012US20120295938 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/22/2012US20120295937 Nitroxide therapy for the treatment of von hippel - lindau disease (vhl) and renal clear cell carcinoma (rcc)
11/22/2012US20120295934 New Hexahydrocyclopentapyrrolone, Hexahydropyrrolopyrrolone, Octahydropyrrolopyridinone and Octahydropyridinone Compounds
11/22/2012US20120295924 Thienopyrimidinedione derivatives as trpa1 modulators
11/22/2012US20120295919 Arylpiperazine opioid receptor antagonists
11/22/2012US20120295909 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application
11/22/2012US20120295902 Hetaryl-[1,8]naphthyridine derivatives
11/22/2012US20120295900 1,3-oxazines as bace 1 and/or bace2 inhibitors
11/22/2012US20120295897 Spiro-oxindole compounds and their uses as therapeutic agents
11/22/2012US20120295896 Oxadiazole inhibitors of leukotriene production
11/22/2012US20120295889 3-Arylamino Pyridine Derivatives
11/22/2012US20120295888 Use of an adrenal hormone-modifying agent
11/22/2012US20120295884 Complement pathway modulators and uses thereof
11/22/2012US20120295877 Therapeutic Compounds
11/22/2012US20120295845 Imidazo-pyrazoles as gpr119 inhibitors
11/22/2012US20120295836 GLP-I Agonist And Cardiovascular Complications
11/22/2012US20120295835 Sgef controls macular, corpus callosum and hippocampal function and development, liver homeostasis, functions of the immune system, fever response atherosclerosis and tumorogenic cell growth
11/22/2012US20120294946 Modulator
11/22/2012US20120294945 Drug delivery system using hyaluronic acid-peptide conjugate micelle
11/22/2012US20120294906 Sericin extracted fabrics
11/22/2012US20120294905 Lipid Formulated Compositions And Methods For Inhibiting Expression Of Transthyretin (TTR)
11/22/2012US20120294901 Novel cochleate formulations
11/22/2012US20120294895 Protein a compositions and methods of use
11/22/2012US20120294877 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
11/22/2012US20120294865 Integrin Alpha-2 Binding Agents and Use Thereof to Inhibit Cancer Cell Proliferation
11/22/2012US20120294861 Fgfr1 agonists and methods of use
11/22/2012US20120294838 Regulation of endogenous gene expression in cells using zinc finger proteins
11/22/2012US20120294835 Substituted pyridines and pyrimidines
11/22/2012US20120294834 Regeneration of, reestablishing function in and replacing microvasculature in organs and tissues
11/22/2012US20120294830 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
11/22/2012US20120294797 Anti-cgrp compositions and use thereof
11/22/2012CA2835913A1 Use of cathepsin k inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure
11/21/2012EP2524693A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability
11/21/2012EP2523963A1 2,5-substituted oxazolopyrimidine derivatives
11/21/2012EP2523962A1 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
11/21/2012EP2523961A1 2,5,7-substituted oxazolopyrimidine derivatives
11/21/2012EP2523960A1 Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
11/21/2012EP2523958A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
11/21/2012EP2523559A1 Compounds and methods
11/21/2012CN202537981U Nitroglycerin patch
11/21/2012CN102791719A Crystal of diamine derivative and method of producing same
11/21/2012CN102791717A Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
11/21/2012CN102791716A 2,5,7-substituted oxazolopyrimidine derivatives
11/21/2012CN102791710A 5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases
1 ... 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 ... 1595